TRIGA-S

Executive Summary

TRIGA-S is a German contract research organization (CRO) founded in 1998, specializing in clinical and analytical performance studies for in vitro diagnostics (IVD). Operating from its own BSL2-certified laboratory in Berlin, the company offers a comprehensive suite of services including contract laboratory work, sample management, clinical operations, and biostatistics. With over two decades of experience, TRIGA-S has built a reputation for quality, regulatory compliance, and trustful collaboration with IVD developers worldwide. The company serves as a critical partner for diagnostic companies navigating the complex regulatory landscape, particularly in Europe under IVDR. Its deep expertise and established infrastructure position it well to capitalize on the growing demand for specialized CRO services in the diagnostics sector. TRIGA-S operates in a fragmented but expanding market driven by increasing IVD development activity and regulatory requirements. While the company does not disclose financials and is privately held, its long-standing presence and specialized focus suggest a stable business with moderate growth potential. Key opportunities include expanding into companion diagnostics and leveraging its expertise to support developers of novel diagnostic technologies. However, competition from larger global CROs and potential regulatory changes pose risks. Overall, TRIGA-S appears well-positioned as a niche player in the IVD CRO space, though its modest scale may limit upside compared to larger peers.

Upcoming Catalysts (preview)

• Q3 2026ISO 15189 Accreditation for Laboratory70% success
• Q1 2027Strategic Partnership with Major IVD Developer30% success
• Q4 2026Expansion into Companion Diagnostics Services40% success